Replay: Leveraging Novel Technologies to Meet Unmet Medical Needs

DTx Podcast with Eugene Borukhovich

English - November 07, 2023 08:08 - 36 minutes - ★★★★★ - 9 ratings
Health & Fitness Technology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Ep77: Empowering Rehabilitation with AI: Revolutionizing Musculoskeletal Treatment for Improved Adherence

Next Episode: Ep78: The Future of ADHD Treatment: Using a Digital Device to Re-Focus Attention

There are two kinds of people in the world, says Brent Vaughan — those who prefer to make incremental changes with a lower likelihood of failure, and those who aspire to fix (seemingly) intractable problems that have stymied others. Brent falls in the latter category. A serial entrepreneur, former venture capitalist, and current CEO of Cognito Therapeutics (a DTx company that specializes in neurodegenerative diseases), Brent is also uniquely positioned to evaluate the future of next generation digital therapeutics.
Brent and Eugene talk about the differences between prescription and business-to-consumer DTx, the importance of engaging patients and users early on in the development of novel products, and the exciting potential of translational DTx solutions. Eugene’s podcast partner, Brian Dolan, also pops in with a question.

Guest Links and Resources:

Connect with Brent Vaughan: LinkedIn

Visit Cognito Therapeutics: Twitter | LinkedIn | Facebook | Website

Host Links:

Connect with Eugene Borukhovich: Twitter | LinkedIn

Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn

Connect with YourCoach.health: Website | Twitter

Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App

HealthXL: Website | Twitter | Join an Event

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health

Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Brent and Eugene talk about the differences between prescription and business-to-consumer DTx, the importance of engaging patients and users early on in the development of novel products, and the exciting potential of translational DTx solutions. Eugene’s podcast partner, Brian Dolan, also pops in with a question.